The macrophage is the natural niche of Mycobacterium tuberculosis infection. In order to combat oxidative and nitrosative stresses and persist in macrophages successfully, M. tuberculosis is endowed with a very efficient antioxidant complex. Amongst these antioxidant enzymes, TpX is the only one in M. tuberculosis with sequence homology to thiol peroxidase. Previous reports have demonstrated that the M. tuberculosis TpX protein functions as a peroxidase in vitro. It is the dominant antioxidant which protects M. tuberculosis against oxidative and nitrosative stresses. The level of the protein increases in oxidative stress. To determine the roles of tpx gene in M. tuberculosis survival and virulence in vivo, we constructed an M. tuberculosis strain lacking the gene. The characteristics of the mutant were examined in an in vitro stationary phase model, in response to stresses; in murine bone marrow derived macrophages and in an acute and an immune resistant model of murine tuberculosis. The tpx mutant became sensitive to H2O2 and NO compared to the wild type strain. Enzymatic analysis using bacterial extracts from the WT and the tpx mutant demonstrated that the mutant contains reduced peroxidase activity. As a result of this, the mutant failed to grow and survive in macrophages. The growth deficiency in macrophages became more pronounced after interferon-γ activation. In contrast, its growth was significantly restored in the macrophages of inducible nitric oxide synthase (iNOS or NOS2) knockout mice. Moreover, the tpx mutant was impaired in its ability to initiate an acute infection and to maintain a persistent infection. Its virulence was attenuated. Our results demonstrated that tpx is required for M. tuberculosis to deal with oxidative and nitrosative stresses, to survive in macrophages and to establish acute and persistent infections in animal tuberculosis models.
Citation: Hu Y, Coates ARM (2009) Acute and Persistent Mycobacterium tuberculosis Infections Depend on the Thiol Peroxidase TPX. PLoS ONE 4(4): e5150. https://doi.org/10.1371/journal.pone.0005150
Editor: Paulo Lee Ho, Instituto Butantan, Brazil
Received: October 31, 2008; Accepted: March 9, 2009; Published: April 2, 2009
Copyright: © 2009 Hu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by the European Community's Sixth Framework Programme to the project NEWTBDRUGS. The publication reflects only the author's views. The European Community is not liable for any use that may be made of the information herein. The financial support of the Burton Medical Trust is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Mycobacterium tuberculosis lives and survives in macrophages which generate antimicrobial radicals such as reactive oxygen species (ROS) and reactive nitrogen species (RNS) especially after activation with interferon gamma . ROSs are produced by the macrophage NADPH oxidase (Phox) which reacts with molecular oxygen to form superoxide (O2−). O2− then can be converted to the toxic H2O2 and the hydroxyl radical . The RNSs are generated by the inducible nitric oxide synthase (NOS2). Also NO and superoxide can react to form highly toxic products such as peroxynitrite , . As a successful intracellular pathogen, M. tuberculosis has evolved with powerful defence strategies to detoxify superoxide and nitric oxide  in order to maintain its viability and to achieve long-term persistence in human organs. The mechanisms by which M. tuberculosis detoxifies ROI and RNI are of particular interest because this knowledge will help us to understand the organism's pathogenesis and its ability to persist, which in turn leads to latent infection. As in other bacteria, M. tuberculosis has an array of enzymes with 22 detoxification genes  encoding catalases, peroxidases , ,  and superoxide dismutases ,  which may have roles in the detoxification and metabolism of reactive oxygen and nitrogen species. M. tuberculosis katG encodes an enzyme which exhibits both catalase, peroxidase and peroxynitritase activities which detoxify and metabolise the reactive oxygen and nitrogen species , , , . The peroxiredoxin-type peroxidases, alkyl hydroperoxide reductase (AhpC) and thioredoxin peroxidase (TpX) have important antioxidant protection of this organism against oxidative and nitrosative stresses , , , , . Also KatG and AhpC mediate resistance of M. tuberculosis to isoniazid . M. tuberculosis contains only one tpx (Rv1932) encoding a putative thiol peroxidase . The TpX has been characterised as a single cysteine peroxiredoxin with cys60 which serves as a reaction site for either oxidising or reducing substrates . The activity of the M. tuberculosis TpX with thioredoxin as an electron donor in the reaction with hydroperoxides and peroxynitrite is significantly greater than that of AhpC  suggesting that TpX is the most efficient enzyme to provide protection of M. tuberculosis against oxidative and nitrosative stress. Also multiple thioredoxin-mediated pathways play important roles in the detoxification of hydroperoxides in M. tuberculosis , . Although the physical property and structure of M. tuberculosis TpX as a peroxiredoxin have been studied in vitro , , , , its role in M. tuberculosis virulence and pathogenesis has not been explored. In Escherichia coli, a tpx deleted mutant grew slower than the WT strain and became sensitive to oxidative-stress , indicating that the TpX protein functions in vivo as a peroxidase. Expression of a yeast thioredoxin peroxidase renders E. coli resistant to oxidative stress induced by singlet oxygen . In Enterococcus faecalis, analysis of mutants lacking three peroxidases including a NADH peroxidase, an Alkyl hydroperoxide reductase and a thiol peroxidase (tpx), respectively or a triple mutant revealed that TpX showed the most significant antioxidant activity to protect the bacterium to survive in macrophages. Also the tpx mutant was attenuated in a mouse peritonitis model .
To determine the roles of tpx gene in M. tuberculosis survival and virulence in vivo, we generated a tpx deleted mutant. The characteristics of the mutant were examined in an in vitro stationary phase model , in response to stresses, in murine bone marrow derived macrophages and in an acute and an immune resistant model of murine tuberculosis . We demonstrated that the tpx mutant is sensitive to the reactive oxygen and nitrogen species. The mutant failed to survive in macrophages and in murine tuberculosis models.
Materials and Methods
Bacterial strains and growth conditions
Escherichia coli XL1 was used as a host strain for cloning and plasmid propagation. E. coli strains were cultured in or on liquid and solid Luria-Bertani medium. M. tuberculosis strain H37Rv was used as the wild type strain (WT) to construct the tpx mutant. All M. tuberculosis strains were grown in 7H9 medium containing 0.05% Tween 80 supplemented with 10% albumin dextrose complex (ADC; BD) without disturbance for the desired period of time, or on 7H11 agar medium supplemented with oleic albumin dextrose complex (OADC, BD). Antibiotics were used as follows: ampicillin (Sigma) 100 µg/ml, kanamycin (Sigma) 25 µg/ml, gentamicin (Sigma) 20 µg/ml and hygromycin (Invitrogen) 100 µg/ml.
DNA manipulations, PCR and sequencing
All DNA techniques including DNA isolation, ethanol precipitation of DNA, electrophoresis of DNA in agarose and transformation were performed by standard techniques . Enzyme reactions were performed according to the manufacturer's instructions (Invitrogen and New England Biolabs). Plasmids were extracted using a QIAprep Spin Miniprep Kit (Qiagen). PCR was performed in a total volume of 50 µl containing 200 µM each of dATP, dCTP, dGTP and dTTP, 1 µM of each primer, 10 ng of DNA, 1 unit of Hotstar Taq polymerase (Qiagen) and buffer system supplied with the enzyme. The PCR was amplified for 30 cycles (94°C 1 min, 58°C, 2 min and 72°C 3 min), followed by a final extension of 10 min at 72°C. PCR products were purified from agarose gel using a QIAquick Gel Extraction Kit (Qiagen). Both DNA strands were sequenced commercially (Qiagen, German) using the two primers that were used to generate each PCR product.
Construction of an M. tuberculosis tpx mutant
The tpx deleted construct was made using the 2-step mutagenesis strategy as described previously . A PCR product containing the tpx gene (498 bp) and about 1 kb flanking sequences adjacent to each end of the gene was amplified using M. tuberculosis H37Rv genomic DNA as template and primers tpx1 (5′-AATAAGCTTCAGGTTTCGCAGCACCTCGT-3′) and tpx2 (5′-AATAAGCTTGCCCGAAGTGCTCTGCTGAC-3′). The PCR product was cloned into the Hind III site of pGEM3Z (promega) to form pGEMtpx. The tpX gene was deleted by PCR with primers tpxM1 (5′-ATTACGCGTGGGCACAGTCTGCCAAGACC-3′) and tpxM2 (5′-ATTACGCGTGCCGCGCTGGGCGCCTAGGC-3′) which were designed outwardly starting from the start and stop codons of the tpx gene using pGEMtpx as a template. The PCR product which contains only the flanking sequences of the tpx gene was cut with MulI and ligated to form pGEMΔtpx. The flanking sequences were cloned into the Hind III site of p2NIL  to make p2NILΔtpx. A hyg -sacB marker cassette from the pGOAL 19  was cloned into the Pac I site of p2NILΔtpx to form the final mutant construct p2NILΔtpx1 which was electroporated into M. tuberculosis H37Rv cells. The selection of the tpx mutant was performed as described previously . PCR screening of the tpx mutant was performed using the primers tpxCD1 (5′-CCGTCGGTGAGCTACCTGCT- 3′) and tpxCD2 (5′ -TGCGCGATTTCCGGCACCA- 3′) which were designed in the coding region of the tpx gene.
To complement the tpx deletion, a 992 bp DNA fragment containing the tpx gene and 377 bp of upstream sequence was amplified by PCR using primers tpxC1 (5′-AATGAATTCCCGGAAATTCGCGGGCGAA-3′) and tpxC2 (5′-AATGAATTCTCCACGGTGCCATCGCCTT-3′). The PCR product was cloned into the EcoR I sites of the integrating plasmid pYH10 . The construct was transformed into tpx mutant by electroporation and gentamicin resistant transformants were selected.
Estimation of viability under stress conditions
M. tuberculosis strains were grown in 7H9 medium containing 0.05% Tween 80 supplemented with 10% ADC without disturbance for 7 to 10 days. A series of 10 ml standing cultures were used for the determination of CFU counts after exposure to stresses. For oxidative stress, H2O2 (Sigma) or paraquat (Sigma) was added to the cultures at the final concentration of 5 and 10 mM for H2O2 and 10 and 20 mM for paraquat. For nitric oxide stress, diethylenetriamine/nitric oxide adduct (DETA/NO, Sigma) or S-nitrosoglutathione (GSNO, Sigma) was added to the cultures at 1.25, 2.5 and 5 mM for DETA/NO and 5 and 10 mM for GSNO, and then the cultures were incubated at 37°C for 24 hours. CFU counts of the treated cultures and the non-treated cultures were determined. Each stress treatment was carried out in duplicate.
Mouse infection models
Female BALB/c mice (6–8 weeks old) were obtained from Harlan, UK Ltd. M. tuberculosis strains which were grown to mid-log phase at 10 days were resusupended in phosphate-buffered saline (PBS). The mice were intravenously infected with 105 CFU bacterial cells/mouse. At various time points, spleens and lungs from 4 mice were removed rapidly after sacrifice and a sterile autopsy was performed. The organs were transferred into 2 ml tubes each containing 1 ml sterile distilled water and 2 mm diameter glass beads. Lungs and spleens of the mice were homogenised using a FastPrep Instrument (Fisher Scientific) for 40 seconds at 6.5 speed. CFU counts of the organs were performed using the diluted homogenates.
Virulent assay of the M. tuberculosis strains with SCID mice (6–8 week, female, Harlan UK Ltd) were carried out as described previously . Three groups of mice (each contains 9 mice) were intravenously infected with 106 CFU of the WT, mutant and the complemented strains which were grown to mid-log phase. After 4 hours of infection, three mice in each group were sacrificed and CFU counts in lungs and spleens were estimated. The remaining 6 infected mice were observed for 60 days and the death time for each group was recorded. Median survival times were calculated for each group, and statistical analysis was carried out using the log rank tests of survival (GraphPad Prim Software).
The animal husbandry guidelines for this study were followed according to the Animals Scientific Procedures Act, 1986 (an Act of the Parliament of the United Kingdom 1986 c. 14).
Bone marrow derived macrophages were cultured as described previously , . Bone marrow cells were flushed from the femurs of BALB/c, C57BL/6 and iNOS knockout mice (C57BL/6 iNOS−/−) (6–8 week old) and cultured in Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with 10% Foetal Bovine Serum (Invitrogen), 20% L-cell conditioned medium, 4500 mg/L of D-glucose, 4 mM of L-glutamine. 110 mg/L of sodium pyruvate, 100 U/ml of penicillin and 100 µg/ml of streptomycin at 37°C, 5% CO2 for 7 days. Adherent macrophages were washed 3 times with warm Hanks' buffered salt solution (HBSS, Sigma). The macrophages were harvested and seeded at 1.25×105 cells per well in the 24 well plates in the above culture medium without L-cell conditioned medium and antibiotics. Activation of the bone marrow derived macrophages was carried out by the addition of γ-interferon (IFN-γ, 100 U/ml. R&D Systems) for 24 hours and followed by the addition of lipopolysaccharide (LPS, 200 ng/ml, Sigma) for 3 hours. The cells were infected with the WT, tpX mutant and the complemented strain at a multiplicity of infection of 1∶1 for 4 hours, and then the cells were washed 5 times with warm HBSS. At day 0, 2, 4 and 6 days after infection, the cells were washed and lysed with 0.1% Triton-X 100. CFU counts were performed at appropriate dilutions of the lysed cell suspension. At each time point, the infected macrophages in two wells were individually harvested using Trypsin- EDTA and stained for acid-fast bacilli to check if the bacilli were maintained inside macrophage in order to verify macrophage viability. The infection experiments were carried out in duplicate for three times.
Measurement of peroxidase activity in WT, Δtpx and the complemented strains
Peroxidase activity was determined using the cell lysates of the WT, tpx mutant and the complemented strains with H2O2 as a substrate. The decomposition of H2O2 was measured using xylenol orange assay which detects peroxide based on oxidation of ferrous to ferric ion in the presence of xylenol orange and provides a sensitive colorimetric measurement spectrophotometrically at 560 nm. PeroXOquant™ Quantitative Peroxide Assay Kit (Pierce) was used. M. tuberculosis strains were grown in 7H9 medium containing 0.05% Tween 80 supplemented with 10% ADC without disturbance for 10 days. Bacterial numbers of the cultures were determined by optical density reading at 600 nm and CFU counts. The cultures were washed three times with water. The cell pellets were transferred into 2 ml tubes each containing 1 ml sterile distilled water and 75 to 150 µm glass beads and lysed by homogenisation using a FastPrep Instrument (Fisher Scientific) for 40 seconds at 6.5 speed. The cell debris was removed by centrifugation at 13,000 rpm for 20 minutes followed by filtration. Total protein concentrations of the cell lysates were determined with the Bio-Rad protein assay using BSA as a standard. 20 µl of reaction mixture containing H2O2 and the cell homogenate was added to 200 µl of working reagent of PeroXOquant™ kit and then incubated at room temperature for 30 min. The remaining amount of H2O2 was determined by measuring the absorbance at 560 nm. The cell homogenate containing the same amount of total protein derived from 107 bacterial cells from WT, tpx mutant and the complemented strain was used for all reactions.
M. tuberculosis tpx mutant construction
Construction of the tpx mutant was performed using a two-step mutagenesis strategy . Complete in-frame deletion of the tpx gene was carried out by PCR using the method as described previously . The generation of the mutant strain was confirmed by Southern blotting analysis (Fig. 1A) and PCR (Fig. 1B) in which no PCR product was amplified in the mutant using the primers tpxCD1 and tpxCD2 which were designed in the coding region of the gene. Both sequences of the PCR product amplified from the mutant were analysed by DNA sequencing to confirm the deletion of the tpx gene (data not shown). The tpx deleted M. tuberculosis H37Rv strain was termed YHΔtpx.
A. Southern blotting analysis of DNA from the WT and the YHΔtpx. which was digested with EcoRV and PvuI and hybridized with a probe synthesized to make the complemented construct. B. PCR amplification of DNA from the WT and the YHΔtpx. 1. WT, 2. tpx mutant. The primers used were designed in the coding region of the tpx gene. 3. WT, 4. tpx mutant. The primers used were for the amplification of complemented construct. M, molecular weight marker (Invitrogen). The experiments were repeated twice, with identical results.
In order to complement the deletion of tpx gene, a 992 kb DNA fragment which contains the tpx coding region frame and the 377 bp upstream sequence of the gene was cloned into plasmid pYH10. The construct was transformed into the YHΔtpx followed by selection for gentamicin resistance. The success of the complementation was confirmed by PCR (data not shown) and the strain was termed as YHtpxComp.
The tpx gene contributes to survival under oxidative and nitrosative stress conditions in vitro.
The WT, YHΔtpx and YHtpxComp M. tuberculosis H37Rv strains were grown in 7H9 broth without disturbance for 100 days as described previously . The viability of these strains was determined by CFU counts at different time points. Growth characteristics of the mutant were similar to those of the wild-type strain (data not shown), indicating that the tpx product is not required for the bacterium to grow in vitro.
In order to determine the contribution of the tpx gene in the response of M. tuberculosis to oxidative and nitrosative stresses, the following experiment was performed: the WT, YHΔtpx and YHtpxComp were treated with H2O2 and DETA/NO which is a slow-release NO donor with a long half-life of about 20 hours for the liberation of NO . Comparison of the survival rate of the mutant with the WT strain revealed significant differences in response to the stress conditions. As shown in Fig. 2A, after H2O2 treatment for 24 hours, viability of the strains decreased. However, compared with the WT strain, the tpx mutant became more sensitive to H2O2. At 5 mM and 10 mM of H2O2, there was a reduction of 0.64 and 2.55 logs in CFU counts for the WT strain whereas the reduction was 2.25 and 5 logs for the mutant (P<0.0001, H2O2 at 5 mM and 10 mM, respectively). A similar pattern was seen after DETA/NO treatment (Fig. 2B). At 1.25 and 2.5 mM of DETA/NO, there was no decrease in CFU for the WT strain but 1.4 and 2.52 log kill in the mutant, respectively. At 5 mM, there was 3.87 log decreases in the mutant in contrast to 1 log kill in the WT. The difference in reduction of CFU counts is significant between the WT strain and the mutant (P<0.0001 NO at 1.25, 2.5 and 5 mM. determined by student's T test, n = 3). The reduced tolerance to H2O2 and NO of the mutant was recovered in the complemented strain. The survival of the mutant under these stress conditions was also examined using paraquat and GSNO, a NO donor, and similar results to H2O2 and DETA/NO were observed (Fig. 2C and 2D). These results suggest that the tpx gene product plays important roles in the oxidative and nitrosative stress survival of M. tuberculosis.
Survival of YHΔtpx compared with WT and the complemented strains in response to H2O2 at 5 and 10 mM (A), DETA/NO at 1.25, 2.5 and 5 mM (B), paraquat at 10 and 20 mM (C) and GSNO at 5 and 10 mM (D). The data shown is a representative of three independent experiments. Data are represented as mean±SD of triplicate tests. The CFU counts in the Δtpx are significantly lower using a t-test than in WT after exposure to both H2O2 and NO for 24 hours (p<0.0001 all concentrations for both stress conditions).
The tpx gene contributes virulence in mice
In order to examine if the tpx mutant is able to grow and persist in vivo, a medium-dose i.v. mouse infection model  was used in which the mice possess an immune response that restricts bacterial growth after two to three weeks of infection but fail to eliminate the bacilli. The WT, YHΔtpx and YHtpxComp were intravenously injected into the BALB/c mice with 105 CFU of bacilli per mouse. The viability of the bacterial strains was determined by CFU counts for 15 weeks. As shown in Fig. 3, the CFU counts of the WT strain reached a peak at three weeks of infection in the mouse lungs (Fig. 3A) and at two weeks of infection in spleens with log 6.3 CFU/organ (Fig. 3B), then the bacterial numbers remained relatively constant up to 15 weeks of infection. However, the YHΔtpx failed to grow in both lungs and spleens after initial infection. At 15 weeks, there were 1.35 log and 2.35 log remaining in the lung and spleen, respectively. The parental levels of the CFU counts from lungs and spleens were recovered in the complemented strain. There were significant differences in CFU counts between the WT and the mutant infected organs (p<0.0001).
Mice were infected with 3 × 105 bacteria. At different time points the infected mice were sacrificed and the numbers of bacteria in the lung (A) or spleen (B) were measured. The results for each time point are the means and SDs of four mice in each experimental group. The experiments have been reproductively repeated twice with similar CFU counts in lungs and spleens. Statistical significance was determined by Student's t test (***, P<0.0001). C. Changes in spleen gross anatomy after infection with the WT, the mutant and the complemented strains. Spleens were collected at 2 and 3 weeks after infection. D. Lung histology of mice infected with the WT, the mutant and the complemented strains. Histopathological examination was performed using three mice in each group. Three sections from each mouse were examined. The images shown are representative of lung sections from three animals in each experimental group. Enlarged images of the boxed regions on the left panel (magnification, 4×) are shown on the right panel (magnification, 10×).
To examine if the mice infected with the tpx mutant produced more inflammatory response than those infected with the WT strain, which inhibited the growth of the mutant in the mouse organs, the spleen gross anatomy was observed. As shown in Fig. 3C, after two and three weeks of infection, enlarged spleen sizes were seen in the WT strain infected mice. In contrast, the tpx mutant infected spleens were of similar size to those of the non-infected mice, indicating that the tpx mutant failed to induce the host's inflammatory response against the bacterial infection.
Histopathological examination of the lungs infected with the mutant and the WT strains demonstrated a marked difference. As shown in Fig. 3D, at 15 weeks of infection, there are large areas of granulomatous inflammation with increased numbers of inflammatory cells including lymphoplasmacytic cells, macrophages, neutrophils and multinucleated cells in the WT strain infected lungs, but in the mutant infected lungs, only very occasional inflammatory cells are present in the alveolar walls with normal alveoli and airways evident throughout the lungs.
In order to examine if the mutant was able to establish an acute infection, we infected SCID mice with the WT, the mutant and the complemented strains. Median survival times for the mice were observed over 60 days after infection. Similar CFU counts of the WT, YHΔtpx and YHtpxComp were recovered from mouse lungs and spleens after 4 hours of infection (CFU counts: WT, 5.88 logCFU/lung and 6.02 logCFU/spleen. YHΔtpX, 5.87 logCFU/lung and 6.01 logCFU/spleen. YHtpXComp, 5.87 logCFU/lung and 5.99 logCFU/spleen). As shown in Fig. 4, the median survival time of the WT strain infected mice was 23 days. However, the mice infected with the mutant remained healthy and no death was observed for 60 days. The parental level of virulence was significantly restored in the complemented strain (p<0.001).
The tpx gene is essential for growth and survival in macrophages
In order to investigate if the failure to grow in the mouse organs is due to the inability of the mutant to survive inside the macrophages, we examined the growth and survival of the mutant in resting and IFN-γ activated murine bone marrow derived macrophages which generate an oxidative burst by producing ROS and RNS . As shown in Fig. 5A, in the resting macrophages the cell numbers of WT increased, but the CFU counts of the mutant decreased significantly after infection, and there is 2.54 log decrease of CFU counts in the mutant compared with the WT strain at 6 days of infection. In the activated macrophages, the reduction of CFU counts in the mutant was much more pronounced, at 6-days of post infection, 0.5 logs of the mutants cells were recovered (Fig. 5). In both resting and activated macrophages, the CFU counts recovered from the macrophages at time 0 were similar between the WT and the mutant, indicating that the mutant retained its ability to invade macrophages, but failed to grow and survive in them. The complemented strain showed a similar growth rate to the WT strain. These data suggest that tpx is essential for M. tuberculosis to overcome stresses and to survive in macrophages.
A. Infection in resting bone marrow derived macrophages from BALB/c mice. B. Infection in IFNγ activated bone marrow derived macrophages from BALB/c mice. These results are the means and standard deviation derived from one representative of three independent experiments. C. Infection in resting bone marrow derived macrophages from C57BL/6 mice. D. Infection in IFNγ activated bone marrow derived macrophages from C57BL/6 mice. E. Infection in resting bone marrow derived macrophages from iNOS KO mice. F. Infection in IFNγ activated bone marrow derived macrophages from iNOS KO mice. The results are the means and SDs derived from triplicate wells. The experiments have been reproductively repeated once. Solid square: WT M. tuberculosis H37Rv. Open square: YHΔtpx. Solid triangle, YHtpxComp.
In order to verify that the failure of the mutant to survive in macrophages is due to the mutant's loss of its ability to detoxify reactive nitrogen species, we infected the iNOS KO mice and C57BL/6 (WT) mice with M. tuberculosis WT, YHΔtpx and the complemented strains. As shown in Fig. 5C and 5D, in the macrophages of C57BL/6, the tpx mutant failed to survive in both resting and activated macrophages which is similar to the growth in the macrophages of BALB/c mice. However, in the iNOS KO macrophages, the growth of the tpx mutant was significantly restored. About 1 log kill of the mutant was seen in both activated and resting macrophage at 6 days of infection. In contrast, there are 3.64 and 2.68 log kill in macrophages of WT mice.
The tpx mutant has reduced peroxidase activity
In order to further investigate that the tpx mutant was unable to decompose peroxides, peroxidase activities of the WT, HYΔtpx and HYtpxComp were measured using xylenol orange assay. Equal amounts of total protein from 107 bacterial cells were used in each reaction containing 1 mM and 0.5 mM of H2O2. The remaining H2O2 level was measured by comparing the difference between the test and the standard curve generated with H2O2. As seen in Fig. 6, the WT strain contained a high level of peroxidase activity and a significant reduction of H2O2 was seen. There are 0.32 mM and 0.18 mM of H2O2 remaining with initial addition of H2O2 concentration at 1 and 0.5 mM, respectively. In contrast, a low level of peroxidase activity was seen in the tpx mutant. There are 0.72 and 0.3 mM H2O2 remaining. There are significant differences in the enzyme activities between the WT and the mutant strains (p<0.0001). The peroxidase activity was restored in the complemented strain.
In this study we successfully generated an M. tuberculosis strain lacking the tpx gene. Our Δtpx strain showed increased susceptibility to exogenously provided H2O2 and nitric oxide (Fig 2). The oxidative activity of tpx mutant was significantly reduced when measured using a biochemical assay with the cell extract compared to the WT strain (Fig. 6). This demonstrates that TpX's biological function is a thiol-dependent peroxidase. We clearly demonstrated that the tpx mutant failed to grow in macrophages of WT mice which are capable of generating an oxidative burst and this die-off was exaggerated after the macrophages were activated with interferon gamma (Fig. 5). In addition, the growth of the mutant was significantly restored in macrophages of iNOS knockout mice which produce a limited oxidative burst . The growth phenotype of the tpx mutant in iNOS KO macrophage further demonstrated that the tpx mutant lacks the ability to decompose peroxides and nitric oxides. Further more, the mutant failed to initiate an acute infection in both immune deficient and immune competent mice and failed to maintain a persistent infection. This indicates that TpX is essential to protect M. tuberculosis against RNS and ROS.
How do these findings of the tpx mutant compare with those for the peroxiredoxin-type peroxidases, AhpC and other enzymes which also protect M. tuberculosis against oxidative and nitrosative stresses , , , , ? Deletion of ahpC (ahpC::KmR) in M. tuberculosis resulted in an increased sensitivity to peroxynitrite. This mutant failed to grow and survive in macrophages, and died more quickly in activated macrophages . It has been shown that M. tuberculosis ahpC gene could complement the loss of the same gene in Salmonella typhimurium in which the mutant was hypersensitive to reactive nitrogen intermediates . However, in another report, an ahpC::Km(r) mutant strain  showed no increased sensitivity to H2O2 but became sensitive to cumene hydroperoxide exposure which implies that it can only degrade organic hydroperoxides. This mutant showed no growth changes in mice compared to the WT strains. A previous report  showed that deletion of katG results in attenuation of the M. tuberculosis mutant in wild-type C57Bl/6 and NOS2(−/−) mice lacking nitric oxide synthase, but showed no growth deficiency in gp91(Phox−/−) mice which lack the gp91 subunit of NADPH oxidase. This indicates that KatG catabolizes the peroxides generated by the phagocyte NADPH oxidase. However, the deficiency of the katG mutant in C57Bl/6 mice was only observed during the periods of 2–4 week of post infection, no further decrease in viability was seen afterward suggesting that the katG gene is required for the bacterium to survive in mice for a certain period of time. Another M. tuberculosis mutant which produced a reduced level of SOD using antisense-sodA was sensitive to killing by hydrogen peroxide which led to attenuation of the mutant in mouse lungs and spleen . A further M. tuberculosis mutant, which had a copper and zinc-cofactored Superoxide dismutase (sodC) deletion , was more susceptible to superoxides and hydrogen peroxide than its parental strain, but grew at the same rate in guinea pigs as the WT strain. This indicates that mycobacterial sodC is not essential for intracellular growth within macrophages and does not contribute to M. tuberculosis pathogenicity in the guinea-pig. However, in another separate report, a sodC knockout mutant of M. tuberculosis was sensitive to ROS and RNS killing in vitro and in macrophages , especially in activated macrophages. But significant killing of the mutant was only seen during the first 6 hours of infection, after which the viability of the mutant leveled off, indicating that there are other enzymes which compensate for the loss of sodC. Deletion of all these genes results in the loss of tolerance to either oxidative or nitrosative stress. It is difficult to compare the activities of these enzymes in response to stress conditions because these mutants were generated in different studies. In Enterococcus faecalis, analysis of three mutants  which lack NADH peroxidase, alkyl hydroperoxide reductase and thiol peroxidase revealed that the viability of the tpx mutant reduced the most in response to oxidative stress and growth in macrophages. This suggests that TpX is the most important antioxidant in the protection of the bacterium against stress conditions. Furthermore the tpx mutant was attenuated in a mouse peritonitis model , In addition, in vitro enzymatic analysis of M. tuberculosis TpX and AhpC with different hydroperoxides including peroxynitrite showed that the TpX was more efficient and faster in peroxynitrite reduction than AhpC . Also the protein level of TpX in M. tuberculosis is considerably higher than that of AhpC , . Unlike the katG mutant  and the sodC mutant , in our study, the increased kill of the tpx mutant in activated macrophages (Fig. 5) and in mice (Fig. 3 and 4) indicates there are no alternative antioxidant activities which are able to compensate for the loss of tpx. All these data suggest that tpx plays a dominant role in vivo to protect M. tuberculosis in its environment when challenged with oxidative and nitrosative stresses.
The growth deficiency of our tpx mutant in mice suggests that thiol peroxidase is essential for the bacterium to initiate growth and to persist in the face of host innate and acquired immunity. The tpx mutant failed to replicate and grow in the SCID mice (Fig. 4) which mount normal innate immune responses, including natural killer cells, macrophages and granulocytes but are immunodeficient in both B and T lymphocytes, and led to no death of the mice. Also in the immune competent mice, the mutant failed to replicate immediately after infection. All these data indicate that innate immune responses are sufficient to kill the mutant, as seen in the resting macrophages which produced limited oxidative burst . The CFU counts of the tpX mutant continued to fall when the acquired immune response became established after 2 to 3 weeks of infection (Fig. 3A and 3B). The acquired immune response evidence by the granuloma formation is closely associated with increased expression of inducible nitric oxide synthase (NOS2) in granuloma macrophages and enhanced levels of nitrate/nitrite circulating in infected mice . As a result of this, M. tuberculosis needs to constantly battle with ROS and RNS in order to establish a latent infection. The tpx mutant does not stimulate enhanced host immune responses, unlike the sodA mutant in which loss of virulence is due to an increased innate host immune response induced by the mutant itself . An enlarged spleen is a marker for an increased level of host inflammatory response to bacterial infection , , , Splenomegaly develops in tuberculosis infection , . In our experiments, during the first three weeks of infection, the spleen size of the WT strain infected mice was significantly enlarged (Fig. 3C). However, in the tpx mutant infected mice, the spleen size was the same as the non-infected control mice, indicating no increase in inflammation. Also the histopathological examination of the mouse lungs from both WT and the mutant infected mice revealed that most of the lungs of the mutant infected animals contain normal alveolar spaces and airways (Fig. 3D). These results demonstrate that the failure of the mutant to grow and persist in mouse organs is due to the mutant's inability to withstand oxidative and nitrosative stresses even in resting macrophages, and is not due to its induction of marked inflammatory responses.
In conclusion, our results show that M. tuberculosis tpx is an essential virulence factor. The tpx mutant is unable to establish acute and persistent infection. The major contribution of the tpx gene in M. tuberculosis pathogenesis depends on its antioxidant defense against oxidative and nitrosative stresses, which allows the bacterium to grow and survive in the macrophages.
We thank Neil Stoker, Department of Pathology and Infectious Diseases, The Royal Veterinary College, London, for providing the mutagenesis plasmids and Adrian Hobbs, Department of Pharmacology, University College London for providing the iNOS KO mice.
Conceived and designed the experiments: YH ARC. Performed the experiments: YH. Analyzed the data: YH. Wrote the paper: YH ARC.
- 1. Denis M (1991) Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 132: 150–157.
- 2. Nathan C, Shiloh MU (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97: 8841–8848.
- 3. Bogdan C, Rollinghoff M, Diefenbach A (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12: 64–76.
- 4. Bogdan C, Rollinghoff M, Diefenbach A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173: 17–26.
- 5. Zahrt TC, Deretic V (2002) Reactive nitrogen and oxygen intermediates and bacterial defenses: unusual adaptations in Mycobacterium tuberculosis. Antioxid Redox Signal 4: 141–159.
- 6. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537–544.
- 7. Milano A, De Rossi E, Gusberti L, Heym B, Marone P, et al. (1996) The katE gene, which encodes the catalase HPII of Mycobacterium avium. Mol Microbiol 19: 113–123.
- 8. Wayne LG, Diaz GA (1988) Detection of a novel catalase in extracts of Mycobacterium avium and Mycobacterium intracellulare. Infect Immun 56: 936–941.
- 9. Jaeger T (2007) Peroxiredoxin systems in mycobacteria. Subcell Biochem 44: 207–217.
- 10. Dussurget O, Stewart G, Neyrolles O, Pescher P, Young D, et al. (2001) Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase. Infect Immun 69: 529–533.
- 11. Kusunose E, Ichihara K, Noda Y, Kusunose M (1976) Superoxide dismutase from Mycobacterium tuberculosis. J Biochem 80: 1343–1352.
- 12. Rouse DA, DeVito JA, Li Z, Byer H, Morris SL (1996) Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol 22: 583–592.
- 13. Manca C, Paul S, Barry CE 3rd, Freedman VH, Kaplan G (1999) Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 67: 74–79.
- 14. Wengenack NL, Jensen MP, Rusnak F, Stern MK (1999) Mycobacterium tuberculosis KatG is a peroxynitritase. Biochem Biophys Res Commun 256: 485–487.
- 15. Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD (2004) Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol 52: 1291–1302.
- 16. Dhandayuthapani S, Zhang Y, Mudd MH, Deretic V (1996) Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J Bacteriol 178: 3641–3649.
- 17. Chen L, Xie QW, Nathan C (1998) Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell 1: 795–805.
- 18. Hillas PJ, del Alba FS, Oyarzabal J, Wilks A, Ortiz De Montellano PR (2000) The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis. J Biol Chem 275: 18801–18809.
- 19. Master SS, Springer B, Sander P, Boettger EC, Deretic V, et al. (2002) Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology 148: 3139–3144.
- 20. Trujillo M, Mauri P, Benazzi L, Comini M, De Palma A, et al. (2006) The mycobacterial thioredoxin peroxidase can act as a one-cysteine peroxiredoxin. J Biol Chem 281: 20555–20566.
- 21. Jaeger T, Budde H, Flohe L, Menge U, Singh M, et al. (2004) Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis. Arch Biochem Biophys 423: 182–191.
- 22. Stehr M, Hecht HJ, Jager T, Flohe L, Singh M (2006) Structure of the inactive variant C60S of Mycobacterium tuberculosis thiol peroxidase. Acta Crystallogr D Biol Crystallogr 62: 563–567.
- 23. Rho BS, Hung LW, Holton JM, Vigil D, Kim SI, et al. (2006) Functional and structural characterization of a thiol peroxidase from Mycobacterium tuberculosis. J Mol Biol 361: 850–863.
- 24. Cha MK, Kim HK, Kim IH (1996) Mutation and Mutagenesis of thiol peroxidase of Escherichia coli and a new type of thiol peroxidase family. J Bacteriol 178: 5610–5614.
- 25. Kim SY, Kim EJ, Park JW (2002) Yeast thioredoxin peroxidase expression enhances the resistance of Escherichia coli to oxidative stress induced by singlet oxygen. Redox Rep 7: 79–84.
- 26. La Carbona S, Sauvageot N, Giard JC, Benachour A, Posteraro B, et al. (2007) Comparative study of the physiological roles of three peroxidases (NADH peroxidase, Alkyl hydroperoxide reductase and Thiol peroxidase) in oxidative stress response, survival inside macrophages and virulence of Enterococcus faecalis. Mol Microbiol 66: 1148–1163.
- 27. Hu Y, Mangan JA, Dhillon J, Sole KM, Mitchison DA, et al. (2000) Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J Bacteriol 182: 6358–6365.
- 28. Orme IM (1988) A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis 137: 716–718.
- 29. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning : a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.
- 30. Parish T, Stoker NG (2000) Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146(Pt 8): 1969–1975.
- 31. Parish TSNG (1998) Electroporation of mycobacteria. Parish TSNG, editor. Totowa: Humana press.
- 32. Hu Y, Henderson B, Lund PA, Tormay P, Ahmed MT, et al. (2008) A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infection. Infect Immun 76: 1535–1546.
- 33. Smith DA, Parish T, Stoker NG, Bancroft GJ (2001) Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun 69: 1142–1150.
- 34. Hu Y, Movahedzadeh F, Stoker NG, Coates AR (2006) Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun 74: 861–868.
- 35. Hu Y, Kendall S, Stoker NG, Coates AR (2004) The Mycobacterium tuberculosis sigJ gene controls sensitivity of the bacterium to hydrogen peroxide. FEMS Microbiol Lett 237: 415–423.
- 36. Morley D, Keefer LK (1993) Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 22: Suppl 7S3–9.
- 37. Piddington DL, Fang FC, Laessig T, Cooper AM, Orme IM, et al. (2001) Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun 69: 4980–4987.
- 38. Springer B, Master S, Sander P, Zahrt T, McFalone M, et al. (2001) Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect Immun 69: 5967–5973.
- 39. Dosanjh NS, Rawat M, Chung JH, Av-Gay Y (2005) Thiol specific oxidative stress response in Mycobacteria. FEMS Microbiol Lett 249: 87–94.
- 40. Ehlers S, Kutsch S, Benini J, Cooper A, Hahn C, et al. (1999) NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 98: 313–323.
- 41. Edwards KM, Cynamon MH, Voladri RK, Hager CC, DeStefano MS, et al. (2001) Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am J Respir Crit Care Med 164: 2213–2219.
- 42. Crawford RM, Van De Verg L, Yuan L, Hadfield TL, Warren RL, et al. (1996) Deletion of purE attenuates Brucella melitensis infection in mice. Infect Immun 64: 2188–2192.
- 43. Kawahara M, Suto C, Shibata S, Futohashi M, Rikihisa Y (1996) Impaired antigen specific responses and enhanced polyclonal stimulation in mice infected with Ehrlichia muris. Microbiol Immunol 40: 575–581.
- 44. Chiavolini D, Alroy J, King CA, Jorth P, Weir S, et al. (2008) Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia. Infect Immun 76: 486–496.
- 45. Lefford MJ (1980) Macrophage activation and resistance to pulmonary tuberculosis. Infect Immun 28: 508–515.